Skip to main content
This website uses cookies to ensure you get the best experience. By continuing to use this site, you agree to the use of cookies.

Please note: Your browser does not support the features used on Addgene's website. You may not be able to create an account or request plasmids through this website until you upgrade your browser. Learn more

Please note: Your browser does not fully support some of the features used on Addgene's website. If you run into any problems registering, depositing, or ordering please contact us at [email protected]. Learn more

GFP-RB FL Citations (5)

Originally described in: The chemokine CXCL12 promotes survival of postmitotic neurons by regulating Rb protein.
Khan MZ, Brandimarti R, Shimizu S, Nicolai J, Crowe E, Meucci O Cell Death Differ. 2008 Oct . 15(10):1663-72.
PubMed Journal

Articles Citing GFP-RB FL

Articles
Retinoblastoma tumor-suppressor protein phosphorylation and inactivation depend on direct interaction with Pin1. Rizzolio F, Lucchetti C, Caligiuri I, Marchesi I, Caputo M, Klein-Szanto AJ, Bagella L, Castronovo M, Giordano A. Cell Death Differ. 2012 Jul;19(7):1152-61. doi: 10.1038/cdd.2011.202. Epub 2012 Feb 10. PubMed
A High-Throughput Cell-Based Screen Identified a 2-[(E)-2-Phenylvinyl]-8-Quinolinol Core Structure That Activates p53. Bechill J, Zhong R, Zhang C, Solomaha E, Spiotto MT. PLoS One. 2016 Apr 28;11(4):e0154125. doi: 10.1371/journal.pone.0154125. eCollection 2016. PubMed
RAS specific protease induces irreversible growth arrest via p27 in several KRAS mutant colorectal cancer cell lines. Stubbs CK, Biancucci M, Vidimar V, Satchell KJF. Sci Rep. 2021 Sep 9;11(1):17925. doi: 10.1038/s41598-021-97422-0. PubMed
RB expression confers sensitivity to CDK4/6 inhibitor-mediated radiosensitization across breast cancer subtypes. Pesch AM, Hirsh NH, Michmerhuizen AR, Jungles KM, Wilder-Romans K, Chandler BC, Liu M, Lerner LM, Nino CA, Ward C, Cobain EF, Lawrence TS, Pierce LJ, Rae JM, Speers CW. JCI Insight. 2022 Feb 8;7(3). pii: 154402. doi: 10.1172/jci.insight.154402. PubMed
RB1 loss overrides PARP inhibitor sensitivity driven by RNASEH2B loss in prostate cancer. Miao C, Tsujino T, Takai T, Gui F, Tsutsumi T, Sztupinszki Z, Wang Z, Azuma H, Szallasi Z, Mouw KW, Zou L, Kibel AS, Jia L. Sci Adv. 2022 Feb 18;8(7):eabl9794. doi: 10.1126/sciadv.abl9794. Epub 2022 Feb 18. PubMed

If you have published an article using this material, please email us at [email protected] to have your article added to this page.